Steve Kahn is the founder of NewLeaf Symbiotics. NewLeaf Symbiotics has raised $122M in total funding. Latest round: Series D. Based in St. Louis, Missouri.
Steve Kahn is the co-founder and CEO of NewLeaf Symbiotics, a company that develops and commercializes proprietary microbes for biological inputs. NewLeaf Symbiotics has raised a $20 million Series D funding round from investors including Koch Agronomic Holdings and Leaps by Bayer. The company previously raised a $30 million Series C round in 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library